Study of Efficacy and Safety of Vigadexa in Treating Inflammation and Infection Post-cataract Surgery

An Evaluation of the Prophylactic Efficacy and Safety of the Administration of the Combination Formulation of Moxifloxacin 0.5% and Dexamethasone 0.1% Eye Drops in Inflammation and Infection Post-cataract Surgery

To demonstrate that the combination formulation of Moxifloxacin/Dexamethasone Eye Drop is effective and safe for the prevention of postoperative inflammation as a consequence of cataract extraction surgery.

Inclusion Criteria:

• ≧18 years of age
• able to sign an informed consent and complete all required visits
• intends to have a cataract extraction surgery followed by implantation of a posterior chamber Intraocular lens (IOL)
• Intraocular Pressure (IOP) ≦ 20 millimeters mercury (mmHg)

Exclusion Criteria:

• Uncontrolled glaucoma or IOP
• use of ocular anti-infectious during the study and within 30 days prior to the enrollment, secondary implantation or replacement of IOL in the study eye
• use of steroid during the study or within 14 days prior to enrollment